Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97

Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97–12

Published:2005-06 Issue:2 Volume:62 Page:342-350
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Komaki Ritsuko,Swann R. Suzanne,Ettinger David S.,Glisson Bonnie S.,Sandler Alan B.,Movsas Benjamin,Suh John,Byhardt Roger W.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Does thoracic irradiation improve survival and local control in limited-stage small cell carcinoma of the lung? A meta-analysis;Warde;J Clin Oncol,1992

3. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small cell lung cancer;Murray;J Clin Oncol,1993

4. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;N Engl J Med,1999

5. The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery;McCormick;Cancer J Sci Am,1996

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase Ii Study of Accelerated Hyperfractionated Thoracic Radiotherapy with Dose Escalation to 54 Gy Concurrently with Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Long-Term Results at a Single Institution;2024

2. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

3. Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer;Cancer Biology & Medicine;2023-06-09

4. Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial;Radiotherapy and Oncology;2023-04

5. Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy;Cancer Research and Treatment;2023-01-15